the importance of recgonizing different dlbcl subtypes
Published 8 years ago • 163 plays • Length 1:08Download video MP4
Download video MP3
Similar videos
-
7:16
changes in the classification of dlbcl
-
3:04
applying molecular understanding of dlbcl to management strategies
-
0:37
the importance of diagnosing dlbcl on a molecular level and how it will improve treatment
-
2:21
the role of molecular subtyping in dlbcl and implications for treatment decisions
-
1:12
exciting advances in dlbcl: molecular characterization of subtypes & novel immunotherapeutic agents
-
10:07
understanding diffuse large b-cell lymphoma with bruce cheson, md, facp, faaas, fasco
-
29:38
dlbcl treatment approaches: what you need to know
-
6:35
high grade diffuse large b-cell lymphoma: carole's story
-
1:53
discussion of the two biologies of dlbcl - the gcb and abc subtype and potential targeted therapies
-
1:56
the need for new treatment strategies for patients with dlbcl
-
1:52
an insight into the optimal management of patients with dlbcl
-
2:53
autohct in dlbcl in the car-t era
-
1:45
improving the frontline treatment of dlbcl
-
4:01
first- and second-line treatment in dlbcl
-
1:28
how the standard of care for dlbcl is changing with the introduction of novel agents
-
5:36
mcl0208: identification of novel genomic prognostic factors
-
1:15
personalized medicine for dlbcl
-
1:16
the importance of multidisciplinary collaboration in the classification of lymphomas
-
0:46
advancements in the dlbcl treatment landscape
-
1:51
efficacy of odronextamab in r/r dlbcl & determining the optimal sequencing of immune therapies
-
1:54
the important role of bispecific antibodies in the future treatment of r/r dlbcl
-
2:10
should we treat high-risk dlbcl differently?